Literature DB >> 8138829

Brain- and muscle-type promoters of the dystrophin gene are selected in peripheral lymphocytes and Epstein Barr virus-transformed lymphoblastoid [correction of lymphoplastoid] cells.

H Nishio1, M Matsuo, Y Kitoh, N Narita, M Shimmoto, Y Suzuki, H Nakamura.   

Abstract

Promoter-specific transcripts of the dystrophin gene in peripheral lymphocytes and Epstein Barr virus-transformed lymphoblastoid cells were analysed using reverse transcription-nested polymerase chain reaction. Two DNA fragments, corresponding to the alternative first exons transcribed from either brain- or muscle-type promoters, were both amplified from cDNA prepared from normal lymphocytes and lymphoblastoid cells. The nucleotide sequences of the amplified products were 100% homologous to the 5' termini of the cDNA of brain- and muscle-type dystrophins, respectively. Neither fragment was amplified from the lymphoblastoid cells of a patient with Duchenne muscular dystrophy, who has a partial deletion involving the brain- and muscle-type promoters in the dystrophin gene. These findings showed that the brain-type as well as the muscle-type promoter of the dystrophin gene was active in lymphocytes and lymphoblastoid cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8138829     DOI: 10.1007/bf00869768

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  Improved diagnosis of Duchenne/Becker muscular dystrophy.

Authors:  A H Beggs; L M Kunkel
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity.

Authors:  G Sarkar; S S Sommer
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

3.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons.

Authors:  H G Lidov; T J Byers; S C Watkins; L M Kunkel
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

5.  Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe.

Authors:  M Matsuo; T Masumura; H Nishio; T Nakajima; Y Kitoh; T Takumi; J Koga; H Nakamura
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

6.  Identification of a new DMD gene deletion by ectopic transcript analysis.

Authors:  F Rininsland; A Hahn; S Niemann-Seyde; R Slomski; F Hanefeld; J Reiss
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

7.  Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophy.

Authors:  K M Bushby; N J Cleghorn; A Curtis; I D Haggerty; L V Nicholson; M A Johnson; J B Harris; S S Bhattacharya
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

8.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

9.  Transcription of the dystrophin gene in human muscle and non-muscle tissue.

Authors:  J Chelly; J C Kaplan; P Maire; S Gautron; A Kahn
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

10.  Dystrophin is transcribed in brain from a distant upstream promoter.

Authors:  F M Boyce; A H Beggs; C Feener; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

View more
  1 in total

1.  Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.

Authors:  H Nishio; Y Takeshima; N Narita; H Yanagawa; Y Suzuki; Y Ishikawa; Y Ishikawa; R Minami; H Nakamura; M Matsuo
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.